{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Las Piedras",
      "address_1": "Pridco Industrial Park",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the degradation product testing detected during stability monitoring.",
      "address_2": "Road # 183",
      "product_quantity": "17,169 Packages",
      "code_info": "Lot: 0NCW005, Exp 02/2013",
      "center_classification_date": "20130130",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "state": "PR",
      "product_description": "Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral Administration, Rx Only, Cytotoxic, NDC: 0085-1519-02, Schering Corporation, Kenilworth, New Jersey, 07033",
      "report_date": "20130206",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Schering-Plough Products, LLC",
      "recall_number": "D-139-2013",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "63879",
      "termination_date": "20140103",
      "more_code_info": "",
      "recall_initiation_date": "20121212",
      "postal_code": "00771",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}